Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”

2024-9-1

CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience

2024-9-1

Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020

2024-9-1

Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation

2024-9-1

Prognostic value of pretreatment radiological MRI variables and dynamic contrast-enhanced MRI on radiotherapy treatment outcome in laryngeal and hypopharyngeal tumors

2024-9-1

Integrative prediction model for radiation pneumonitis incorporating genetic and clinical-pathological factors using machine learning

2024-9-1

Radiation response assessment of organoids derived from patients with pancreatic cancer

2024-9-1

Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer – Multi-centre study

2024-9-1

HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases – A dosimetric comparison study of three radioablative techniques

2024-9-1

NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution

2024-9-1

Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)

2024-9-1

Feasibility of using contrast-free quantitative magnetic resonance imaging for liver sparing stereotactic ablative body radiotherapy

2024-9-1

Temporary halo fixation and radiotherapy as alternative to long-construct spondylodesis in patients with multiple unstable cervical metastases

2024-9-1

Remineralization of lytic spinal metastases after radiation therapy – A retrospective cohort study comparing conventional external beam radiation therapy with stereotactic ablative body radiation

2024-9-1

Impact of discrimination on training and career of radiation oncologists in France

2024-9-1

Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study

2024-9-1

Selection criteria and method for deep inspiration breath-hold in patients with left breast cancer undergoing PMRT/IMRT

2024-9-1

Adaptive bridging radiation therapy for relapsed/refractory B-cell lymphoma patient undergoing CAR T-cell therapy: Case report

2024-9-1

Understanding the impact of radiation-induced lymphopenia: Preclinical and clinical research perspectives

2024-9-1

Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study

2024-9-1

Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center

2024-9-1

Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study

2024-9-1

Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer

2024-9-1

Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study

2024-9-1

Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation

2024-9-1

Letter to the Editor

2024-9-1

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma

2024-9-1

Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC

2024-9-1

Exploring long-term outcomes following CyberKnife robotic radiosurgery for trigeminal neuralgia

2024-9-1

The time course of health-related Quality of Life in rectal cancer patients undergoing combined modality treatment

2024-9-1

Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors

2024-9-1

Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy

2024-9-1

Selection for proton radiotherapy of grade 1–3 glioma patients

2024-9-1

The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective study

2024-9-1

Reply to: Comment on “Repeated HyperArc radiosurgery for recurrent intracranial metastases and dosimetric analysis of recurrence pattern to account for diffuse dose effect on microscopical disease”

2024-9-1

CT-based different regions of interest radiomics analysis for acute radiation pneumonitis in patients with locally advanced NSCLC after chemoradiotherapy

2024-9-1

The carbon footprint of external beam radiotherapy and its impact in health technology assessment

2024-9-1

PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer

2024-8-27

In response to Chuong et al.

2024-8-20

Clinical management of oligometastatic cancer: Applying multidisciplinary tumor board recommendations in practice

2024-8-10

Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era – A systematic review

2024-8-1

Cosmetic outcome in patients with early stage breast cancer after accelerated partial breast irradiation using intraoperative or external beam radiotherapy

2024-8-1

Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma

2024-8-1

Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials

2024-8-1

Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the diagnosis of recurrent colorectal cancers

2024-8-1

Incidental dose distribution to contralateral internal mammary nodes in breast cancer patients undergoing adjuvant radiotherapy

2024-7-30

Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis

2024-7-7

Does a peer review group consensus process for MR-Linac patients affect clinical care? Evaluation of impact and feasibility

2024-7-3

Preoperative radiosurgery for brain metastases (PREOP-1): A feasibility trial

2024-7-1

Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma

2024-7-1